Ferraresi V - Search Results

1

Comparison of 18F-FDG PET/CT Criteria for the Prediction of Therapy Response and Clinical Outcome in Patients With Metastatic Melanoma Treated With Ipilimumab and PD-1 Inhibitors.

Annovazzi A, Vari S, Giannarelli D, Pasqualoni R, Sciuto R, Carpano S, Cognetti F, Ferraresi V. Annovazzi A, et al. Among authors: ferraresi v. Clin Nucl Med. 2020 Mar;45(3):187-194. doi: 10.1097/RLU.0000000000002921. Clin Nucl Med. 2020. PMID: 31977479

2

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP, Beppu Y, Le Cesne A, Gelderblom H, Judson IR, Araki N, Ouali M, Marreaud S, Hodge R, Dewji MR, Coens C, Demetri GD, Fletcher CD, Dei Tos AP, Hohenberger P; EORTC Soft Tissue and Bone Sarcoma Group; PALETTE study group. van der Graaf WT, et al. Lancet. 2012 May 19;379(9829):1879-86. doi: 10.1016/S0140-6736(12)60651-5. Epub 2012 May 16. Lancet. 2012. PMID: 22595799 Free article. Clinical Trial.

3

Phase II trial of high-dose epirubicin and cyclophosphamide in advanced breast cancer.

Scinto AF, Cercato MC, Botti C, Tonachella R, Ferraresi V, Del Bianco S, Sacchi I, Cognetti F. Scinto AF, et al. Among authors: ferraresi v. Eur J Cancer. 1994;30A(9):1285-8. doi: 10.1016/0959-8049(94)90174-0. Eur J Cancer. 1994. PMID: 7999414 Clinical Trial.

4

Accelerated chemotherapy with high-dose epirubicin and cyclophosphamide plus r-met-HUG-CSF in locally advanced and metastatic breast cancer.

Scinto AF, Ferraresi V, Campioni N, Tonachella R, Piarulli L, Sacchi I, Giannarelli D, Cognetti F. Scinto AF, et al. Among authors: ferraresi v. Ann Oncol. 1995 Sep;6(7):665-71. doi: 10.1093/oxfordjournals.annonc.a059282. Ann Oncol. 1995. PMID: 8664187 Free article. Clinical Trial.

5

Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal women.

Milella M, Nisticò C, Ferraresi V, Vaccaro A, Fabi A, D'Ottavio AM, Botti C, Giannarelli D, Lopez M, Cortesi E, Foggi CM, Antimi M, Terzoli E, Cognetti F, Papaldo P. Milella M, et al. Among authors: ferraresi v. Breast Cancer Res Treat. 1999 Jun;55(3):259-66. doi: 10.1023/a:1006276120841. Breast Cancer Res Treat. 1999. PMID: 10517170 Clinical Trial.

6

Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study.

Scinto AF, Ferraresi V, Milella M, Tucci E, Santomaggio C, Pasquali-Lasagni R, Del Vecchio MR, Campioni N, Nardi M, Cognetti F. Scinto AF, et al. Among authors: ferraresi v. Br J Cancer. 1999 Nov;81(6):1031-6. doi: 10.1038/sj.bjc.6690803. Br J Cancer. 1999. PMID: 10576661 Free PMC article. Clinical Trial.

7

Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study.

Ferraresi V, Milella M, Vaccaro A, D'Ottavio AM, Papaldo P, Nisticò C, Thorel MF, Marsella A, Carpino A, Giannarelli D, Terzoli E, Cognetti F. Ferraresi V, et al. Am J Clin Oncol. 2000 Apr;23(2):132-9. doi: 10.1097/00000421-200004000-00006. Am J Clin Oncol. 2000. PMID: 10776972 Clinical Trial.

8

Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer.

Zeuli M, Nardoni C, Pino MS, Gamucci T, Gabriele A, Ferraresi V, Giannarelli D, Cognetti F. Zeuli M, et al. Among authors: ferraresi v. Ann Oncol. 2003 Sep;14(9):1378-82. doi: 10.1093/annonc/mdg360. Ann Oncol. 2003. PMID: 12954576 Free article. Clinical Trial.

9

The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II study.

Fabi A, Barduagni M, Ferraresi V, Cortesi E, Gamucci T, De Marinis F, Saltarelli R, Gabriele A, Pellicciotta M, Ceribelli A, De Marco S, Facciolo F, Cognetti F. Fabi A, et al. Among authors: ferraresi v. J Exp Clin Cancer Res. 2004 Mar;23(1):25-32. J Exp Clin Cancer Res. 2004. PMID: 15149147 Clinical Trial.

10

Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedules.

Terzoli E, Nisticò C, Fabi A, Milella M, Bria E, D'Ottavio AM, Vaccaro A, Vanni B, Garufi C, Ferraresi V, Giannarelli D, Papaldo P, Carlini P, Izzo F, Cognetti F. Terzoli E, et al. Among authors: ferraresi v. J Exp Clin Cancer Res. 2004 Jun;23(2):207-13. J Exp Clin Cancer Res. 2004. PMID: 15354404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters